Outcomes for clinical trials involving adults with chronic kidney disease: a multinational Delphi survey involving patients, caregivers and health professionals

Author:

Matus Gonzalez Andrea12ORCID,Evangelidis Nicole12,Howell Martin1ORCID,Jaure Allison12,Sautenet Benedicte3,Madero Magdalena4,Ashuntantang Gloria5,Anumudu Samaya6,Bernier-Jean Amelie12,Dunn Louese7,Cho Yeoungjee8910,Cortes Sanabria Laura11,de Boer Ian H12,Fung Samuel13,Gallego Daniel14,Guha Chandana12,Levey Andrew S15,Levin Adeera16,Lorca Eduardo17,Okpechi Ikechi G18ORCID,Rossignol Patrick19ORCID,Scholes-Robertson Nicole12ORCID,Sola Laura20,Teixeira-Pinto Armando12,Usherwood Tim2122,Viecelli Andrea K89,Wheeler David C2324,Widders Katherine2,Wilkie Martin25,Craig Jonathan C26

Affiliation:

1. Sydney School of Public Health, The University of Sydney , Sydney , Australia

2. Centre for Kidney Research, The Children's Hospital at Westmead , Westmead, Sydney , Australia

3. Department of Nephrology, CHU Tours, INSERM SPHERE U1246, University of Tours, University of Nantes , Tours , France

4. Division of Nephrology, Department of Medicine, Instituto Nacional de Cardiología Ignacio Chávez , Mexico City , Mexico

5. Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaounde I , Yaounde , Cameroon

6. Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine , Houston, TX , USA

7. Sheffield Kidney Institute, Sheffield Teaching Hospitals NHS Foundation Trust , Sheffield , UK

8. Department of Nephrology, Princess Alexandra Hospital , Brisbane, QLD , Australia

9. Australasian Kidney Trials Network, Centre for Health Services Research, University of Queensland , Brisbane, QLD , Australia

10. Translational Research Institute , Brisbane, QLD , Australia

11. Dirección de Educación e Investigación en Salud, Unidad Médica de Alta Especialidad, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social , Guadalajara , Mexico

12. Department of Medicine, Kidney Research Institute, University of Washington , Seattle, WA , USA

13. Division of Nephrology, Department of Medicine & Geriatrics, Princess Margaret Hospital , Hong Kong

14. European Kidney Patient’s Federation, Austria. Federacion Nacional Alcer president, Spanish Kidney Patient’s Federation , Spain

15. Division of Nephrology, Tufts Medical Center , Boston, MA , USA

16. Division of Nephrology, University of British Columbia , Vancouver , Canada

17. Eastern Department of Internal Medicine, Faculty of Medicine, University of Chile, and Hospital del Salvador Nephrology Service , Santiago de Chile

18. Division of Nephrology and Hypertension, University of Cape Town , Cape Town , South Africa

19. Université de Lorraine, Inserm, Centre d'Investigations Clinique and Inserm U1116; CHRU Nancy ; F-CRIN INI-CRCT, Nancy , France

20. Dialysis Unit, CASMU-IAMPP , Montevideo , Uruguay

21. Westmead Applied Research Centre, Faculty of Medicine and Health, The University of Sydney , Sydney, NSW , Australia , Sydney, NSW , Australia

22. ; The George Institute for Global Health, University of New South Wales , Sydney, NSW , Australia , Sydney, NSW , Australia

23. Department of Renal Medicine, University College London

24. , London, UK

25. Department of Nephrology, Sheffield Teaching Hospitals NHS Foundation Trust , UK

26. College of Medicine and Public Health, Flinders University , Adelaide , Australia

Abstract

ABSTRACT Background Many outcomes of high priority to patients and clinicians are infrequently and inconsistently reported across trials in chronic kidney disease (CKD), which generates research waste and limits evidence-informed decision making. We aimed to generate consensus among patients/caregivers and health professionals on critically important outcomes for trials in CKD prior to kidney failure and the need for kidney replacement therapy, and to describe the reasons for their choices. Methods This was an online two-round international Delphi survey. Adult patients with CKD (all stages and diagnoses), caregivers and health professionals who could read English, Spanish or French were eligible. Participants rated the importance of outcomes using a Likert scale (7–9 indicating critical importance) and a Best–Worst Scale. The scores for the two groups were assessed to determine absolute and relative importance. Comments were analysed thematically. Results In total, 1399 participants from 73 countries completed Round 1 of the Delphi survey, including 628 (45%) patients/caregivers and 771 (55%) health professionals. In Round 2, 790 participants (56% response rate) from 63 countries completed the survey including 383 (48%) patients/caregivers and 407 (52%) health professionals. The overall top five outcomes were: kidney function, need for dialysis/transplant, life participation, cardiovascular disease and death. In the final round, patients/caregivers indicated higher scores for most outcomes (17/22 outcomes), and health professionals gave higher priority to mortality, hospitalization and cardiovascular disease (mean difference >0.3). Consensus was based upon the two groups yielding median scores of ≥7 and mean scores >7, and the proportions of both groups rating the outcome as ‘critically important’ being >50%. Four themes reflected the reasons for their priorities: imminent threat of a health catastrophe, signifying diminishing capacities, ability to self-manage and cope, and tangible and direct consequences. Conclusion Across trials in CKD, the outcomes of highest priority to patients, caregivers and health professionals were kidney function, need for dialysis/transplant, life participation, cardiovascular disease and death.

Funder

Agencia Nacional de Investigación y Desarrollo

Becas Chile—Doctorado en el extranjero

National Health and Medical Research Council

Publisher

Oxford University Press (OUP)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3